Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

is too expensive for regular funding on the health service as a maintenance therapy for some ovarian cancer patients. In a first draft decision NICE said Lynparza was not cost effective as a ...

Some common vaccines against infectious diseases already help prevent cancer. The human papillomavirus (HPV) vaccine, for example, protects against the strains of HPV that are most likely to cause ...

of Northwestern University as a second site in a clinical trial combining the Company’s proprietary compound LB-100 with GSK’s Dostarlimab to treat ovarian clear cell cancer. Emily M.

TUESDAY, Feb. 25, 2025 (HealthDay News) -- Breast cancer deaths are expected to increase during the next quarter-century, largely impacting the world’s poorest nations, a new international study ...

The American Society of Clinical Oncology (ASCO) has released updated guidelines for neoadjuvant chemotherapy in newly diagnosed advanced ovarian cancer, introducing changes in patient selection ...

Epithelial ovarian cancer is the most common type of ovarian cancer. About 90 out of 100 tumours of the ovary (90%) are epithelial. Epithelial ovarian cancer starts in the surface layer covering the ...

It weighed about 2 kilos.” Jordan had ovarian dysgerminoma – a rarer form of ovarian cancer more prevalent in younger women. “In my mind, ovarian cancer was associated with older women and ...

Remission rates for ovarian cancer patients remained stable before and after the COVID-19 pandemic, despite treatment delays and protocol changes. The study involved 748 patients, with no ...

Get Instant Summarized Text (Gist) A cryptic antigen has been identified as a new target for immunotherapy in ovarian cancer, potentially enhancing the immune system's ability to combat tumors ...